Effects of dual inhibition of renin–angiotensin–aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefits
Author:
Publisher
Springer Science and Business Media LLC
Subject
Emergency Medicine,Internal Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11739-019-02257-3.pdf
Reference48 articles.
1. Vinhas J, Gardete-Correia L, Boavida JM, Raposo JF, Mesquita A, Fona MC et al (2011) Prevalence of chronic kidney disease and associated risk factors, and risk of end-stage renal disease: data from the PREVADIAB study. Nephron Clin Pract 119(1):c35–40
2. Wagner M, Wanner C, Kotseva K, Wood D, De Bacquer D, Ryden L et al (2017) Prevalence of chronic kidney disease and its determinants in coronary heart disease patients in 24 European countries: Insights from the EUROASPIRE IV survey of the European Society of Cardiology. Eur J Prev Cardiol 24(11):1168–1180
3. De Nicola L, Donfrancesco C, Minutolo R, Lo Noce C, Palmieri L, De Curtis A et al (2015) Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008–12 National Health Examination Survey. Nephrol Dial Transplant 30(5):806–814
4. Mahfoud F, Ukena C, Poss J, Bramlage P, Volpe M, Thoenes M et al (2012) Microalbuminuria independently correlates to cardiovascular comorbidity burden in patients with hypertension. Clin Res Cardiol 101(9):761–766
5. Viazzi F, Cappadona F, Bonino B, Pontremoli R (2016) Chronic kidney disease as a predictor of clinical risk in the elderly. J Geriatr Cardiol 13(3):199–201
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effects of hydroxychloroquine on proteinuria in membranous nephropathy;Journal of Nephrology;2021-11-30
2. ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients;High Blood Pressure & Cardiovascular Prevention;2021-03-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3